Advisory Committee on Immunization Practices Votes to Recommend Pfizer ’s Prevnar 13® Vaccine in Adults Aged 65 Years and Older
UPDATE: U.S. stocks: Futures rise after Merck, Pfizer results
MARKET SNAPSHOT: U.S. Stocks: Futures Rise After Merck, Pfizer Results
UPDATE: Inversions are not such a sweet deal for fund investors
Good day everyone and welcome to Pfizer's First Quarter 2014 Earnings Conference Call. Today's call is being recorded.
Manhattan Scientifics Reaches the Fork (Falk) in the Road
Research and Markets: Competitor Analysis: GLP-1 Receptor Agonists Development Pipeline Report 2014
Research and Markets: Global Non-Small Cell Lung Cancer Market to 2020: Pipeline Entries to Drive NSCLC Market Growth
Top managers continue to exercise a lot of patience as they look for buying opportunities in a U.S. equity market that has risen close to 40% since the start of 2013.
UPDATE: Tax inversions can be bad for shareholders -- and for America